Displaying 1 - 8 of 8 for Cancer - Colon/Rectal
  • AMC-088 Study (H-39190)
    • This randomized phase III trial studies imiquimod or fluorouracil to see how well they work compared to observation in treating patients with high-grade anal squamous skin lesions who are human immunodeficiency virus (HIV)-positive.
  • Biospecimen Banking (H-37203)
    • This study obtains samples from HIV-positive and negative patients with HPV-related cancers of the oropharynx, cervix and anus.
  • CANscriptTM Clinical Outcomes in a Real-World Setting (ANCERS-2) (H-42500)
    • The purpose of this study is to test the CANscript™ sensitivity assay, a new and different assay developed to test the sensitivity of different cancer types to physician selected therapies indicated for the stage and type of cancer for treatment.
  • ICare: Improving Care for Cancer Survivors (H-43629)
    • This study addresses the need to clarify system, provider and survivor-level facilitators of survivorship care plans implementation/use to guide future rollout efforts.
  • Locally Advanced Rectal Cancer, NRG-GI002 (H-41594)
    • This randomized phase II trial studies how well veliparib works with combination chemotherapy and radiation therapy in treating patients with rectal cancer that has spread from where it started to nearby tissue or lymph nodes (locally advanced). 
  • NCI MATCH Screening Trial (H-37222)
    • This clinical trial studies how well treatment directed by genetic testing works in patients with solid tumors or lymphomas that have progressed following at least one line of standard treatment or for which no agreed upon treatment approach exists.
  • NOVA: Colorectal Cancer Study (H-43684)
    • The primary objective of this study is to compare the sensitivity and specificity estimates of Colvera with that of a commercially available CEA test for detection of recurrent disease in CRC subjects who are undergoing surveillance for recurrence.
  • Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction (H-38885)
    • The purpose of this clinical trial is to study surgery or non-surgical management in treating patients with intra-abdominal cancer and bowel obstruction.